These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 31623106)

  • 1. Proteomic Biomarkers for the Detection of Endometrial Cancer.
    Njoku K; Chiasserini D; Whetton AD; Crosbie EJ
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31623106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer.
    Njoku K; Sutton CJ; Whetton AD; Crosbie EJ
    Metabolites; 2020 Jul; 10(8):. PubMed ID: 32751940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer.
    Njoku K; Chiasserini D; Jones ER; Barr CE; O'Flynn H; Whetton AD; Crosbie EJ
    Front Oncol; 2020; 10():559016. PubMed ID: 33224875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in endometrial cancer protein biomarkers for use in the clinic.
    Martinez-Garcia E; Lopez-Gil C; Campoy I; Vallve J; Coll E; Cabrera S; Ramon Y Cajal S; Matias-Guiu X; Van Oostrum J; Reventos J; Gil-Moreno A; Colas E
    Expert Rev Proteomics; 2018 Jan; 15(1):81-99. PubMed ID: 29183259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of proteomic strategies to the identification of urinary biomarkers for prostate cancer: a review.
    Downes MR; Byrne JC; Dunn MJ; Fitzpatrick JM; Watson RW; Pennington SR
    Biomarkers; 2006; 11(5):406-16. PubMed ID: 16966158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine.
    Honda K; Ono M; Shitashige M; Masuda M; Kamita M; Miura N; Yamada T
    Jpn J Clin Oncol; 2013 Feb; 43(2):103-9. PubMed ID: 23248327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
    Núñez Galindo A; Macron C; Cominetti O; Dayon L
    Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics in prostate cancer biomarker discovery.
    Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
    Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
    Shukla HD; Mahmood J; Vujaskovic Z
    Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry for translational proteomics: progress and clinical implications.
    Baker ES; Liu T; Petyuk VA; Burnum-Johnson KE; Ibrahim YM; Anderson GA; Smith RD
    Genome Med; 2012; 4(8):63. PubMed ID: 22943415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial cancer diagnostic and prognostic algorithms based on proteomics, metabolomics, and clinical data: a systematic review.
    Romano A; Rižner TL; Werner HMJ; Semczuk A; Lowy C; Schröder C; Griesbeck A; Adamski J; Fishman D; Tokarz J
    Front Oncol; 2023; 13():1120178. PubMed ID: 37091170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of endometrial cancer in cervico-vaginal fluid and blood plasma: leveraging proteomics and machine learning for biomarker discovery.
    Njoku K; Pierce A; Chiasserini D; Geary B; Campbell AE; Kelsall J; Reed R; Geifman N; Whetton AD; Crosbie EJ
    EBioMedicine; 2024 Apr; 102():105064. PubMed ID: 38513301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The progress of proteomic approaches in searching for cancer biomarkers.
    Kočevar N; Hudler P; Komel R
    N Biotechnol; 2013 Mar; 30(3):319-26. PubMed ID: 23165098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics discovery of radioresistant cancer biomarkers for radiotherapy.
    Chang L; Graham P; Hao J; Bucci J; Malouf D; Gillatt D; Li Y
    Cancer Lett; 2015 Dec; 369(2):289-97. PubMed ID: 26427840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
    Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optomechanical devices for deep plasma cancer proteomics.
    Kosaka PM; Calleja M; Tamayo J
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):26-38. PubMed ID: 28867489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the colorectal cancer proteome for biomarkers: Current status and perspectives.
    Lee PY; Chin SF; Low TY; Jamal R
    J Proteomics; 2018 Sep; 187():93-105. PubMed ID: 29953962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary biomarkers in prostate cancer detection and monitoring progression.
    Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y
    Crit Rev Oncol Hematol; 2017 Oct; 118():15-26. PubMed ID: 28917266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.